Delivery Order SPE2DB20D3104-SPE2DB23FV6B3

Award Date 4/12/23
Potential Completion Date 5/3/23
Potential Value $5.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $4,468.92 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of 250mg vials of the pharmaceutical product Ryanodex, with a period of performance through October 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to supply medical commodities and prescription drugs to various military treatment facilities, veterans'...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $2,979.28 firm fixed price delivery order is for the supply of Ryanodex 250 mg vials, a specialty pharmaceutical product. This award is associated with a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of Ryanodex 250 mg vials. The contract has a ceiling value of $7,448.20 and a completion date of November 5, 2024. This order is not associated with any set-aside program. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies to provide a wide range of medical products and...
This is a delivery order awarded to AmerisourceBergen Drug Corp Corporate Office Division by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the U.S. Department of Defense. The contract is for the supply of RYANODEX 250 MG VIALS, a pharmaceutical product. The contract has a firm-fixed price ceiling value of $22,344.60 and a completion date of September 6, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,082.24 firm fixed-price delivery order is for the supply of RYANODEX 250 MG VIALS, a critical pharmaceutical product. The award is under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is to provide the pharmaceutical product RYANODEX 250MG VIAL 1S, with a total ceiling value of $5,958.56 and a period of performance through March 27, 2024. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Medical Supply Chain to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of RYANODEX 250 MG VIALS. The $1,489.64 firm fixed-price contract has a completion date of June 25, 2024. Amerisourcebergen, a major pharmaceutical distributor, leverages its extensive supply chain to fulfill government contracts, particularly for the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. The...
This contract award to Amerisourcebergen Drug Corp is a Delivery Order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $22,476.16. The contract is for the supply of RYANODEX 250 MG VIALS, a pharmaceutical product, to support military healthcare programs. The IDC with the DLA Troop Support Medical has a ceiling value of $999,999,999 and runs through November 2026, providing a comprehensive range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 250 mg Ryanodex vials. The contract has a ceiling value of $4,468.92 and an ultimate completion date of August 14, 2024. It is a delivery order contract with a firm fixed-price pricing type. This award is not set aside for any specific business type. Amerisourcebergen Drug Corp's Corporate Office Division is the...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp Corporate Office Division. The $8,937.84 firm-fixed-price delivery order is for the supply of RYANODEX 250 MG VIALS, a pharmaceutical product, with an ultimate completion date of September 26, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA...
  • SPE2DB20D3104
    Indefinite Delivery Contract
  • SPE2DB20D3104-SPE2DB23FV6B3
    Delivery Order

This is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $999,999,999, provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

The specific delivery order is for 250 mg vials of the drug Ryanodex, with a ceiling value of $5,716.40. The order was awarded on April 12, 2023 and has a completion date of May 3, 2023. It is a firm fixed-price contract with no set-aside designation, indicating open competition. As a major pharmaceutical distributor, AmerisourceBergen plays a critical role in supplying essential medical commodities to federal government agencies, particularly the DLA, to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 12:23 PM